In order to identify up-stream regulators and oncogenic signaling pathways that may cause the observed down-regulation of RBM47 in mesenchymal-like cancer cells during tumor progression, we analyzed RBM47 expression after experimental induction of EMT in CRC cell lines. Here, RBM47 is linked to cancer.